Th17 Inducing Cytokines Pregnancy and After Postpartum
Interleukin-17 and Th17 Inducing Cytokines Exacerbate Periodontal Disease During Pregnancy and Postpartum
1 other identifier
observational
114
0 countries
N/A
Brief Summary
The aim of this study was to investigate salivary and gingival crevicular fluid (GCF) levels of IL-17A, IL-17E, IL-6 AND IL-23 during 2/3 trimester of pregnancy and after delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2013
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2018
CompletedFirst Submitted
Initial submission to the registry
January 26, 2018
CompletedFirst Posted
Study publicly available on registry
February 28, 2018
CompletedFebruary 28, 2018
February 1, 2018
1 year
January 26, 2018
February 22, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changing Il-17A levels
Salivary and GCF level measured by ELISA
6 month
Secondary Outcomes (3)
Changing IL-6 levels
6 month
Changing IL-23 levels
6 month
Changing IL-17E levels
6 month
Study Arms (2)
Pregnancy group
Women, who were in their second trimester (weeks 16-24) or third trimester (weeks 25-34)selected for the study. Saliva and GCF samples were collected and clinical periodontal measurements were made gently
Postpartum group
Postpartum women 6 months after giving birth recalled. Saliva and GCF samples were collected and clinical periodontal measurements were made.
Interventions
Eligibility Criteria
All participants had 20 teeth present at least.
You may qualify if:
- women 2 and 3 trimester of their pregnancy
You may not qualify if:
- any known systemic disease,
- periodontal treatment within the last six months,
- patients having less than 10 teeth,
- smokers,
- individuals with a BMI \> 30 kg/m2,
- gestational diabetes and preeclampsia during pregnancy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 9 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 26, 2018
First Posted
February 28, 2018
Study Start
April 1, 2013
Primary Completion
April 1, 2014
Study Completion
January 1, 2018
Last Updated
February 28, 2018
Record last verified: 2018-02